FDA drug approvals | iPharmaCenter

top of page

iPharmaCenter

Global | Comprehensive | Patient Centric

Home
News
Regional News
Healthcare Policies
Disease Information
- Diseases
- Disease News
Conferences
Others
- COVID-19
- Contact

Viber -Pharma and healthcare news on mobile

All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
APAC Drug approvals
US_PayerNews
Australia TGA Approvals

Search

Myelofibrosis | News | Blogs | Updates | GSK | iPharmaCenter

ipharmaservices

Aug 18, 2022

Myelofibrosis | News | Blogs | Updates | GSK | iPharmaCenter

FDA approved Roche’s Gavreto for RET fusion-positive NSCLC

ipharmaservices

Sep 7, 2020

FDA approved Roche’s Gavreto for RET fusion-positive NSCLC

For sponsored articles, link insertions, and advertisements, please write to ipharmaservices@gmail.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

iPharmaCenter Telegran_edited.jpg

bottom of page